Insurance for the Medical Psychedelics Industry in Canada
On January 19th 2022, psychedelics including MDMA and psilocybin were approved by Health Canada through their Special Access Program (SAP) for medical purposes. This approval will provide accessibility to those treating serious or life-threatening conditions that have exhausted other options. Psychedelic-assisted psychotherapy has been found to have significant potential in managing and treating a variety…